Stock screener

TGTX

SetupConviction 71LongHealthcareScan · Thu, Sep 24, 2026
Flat baseInside barbase

Tg Therapeutics, Inc. (TGTX) closed at $57.52 (+2.71%) on Sep 24, 2026. It is in the "Setting up" lane with a flat base pattern. Price is above its 50-day and above its 200-day moving average. RSI(14) 59, RS Rating 91, -2.6% from its 52-week high, +96.5% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

TGTX$57.52+2.71%
ResistanceSupportVol 14
63 bars
Vol MA14 1.87M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Trade plan

LongReward : Risk1.87
Entry
Entry
58.92
Risk
Stop
55.27
-6.2% to stop
Reward
Target 1
65.73
+11.6% to target
Stretch
Target 2
72.54
+23.1% to T2
Risk : reward balance
Risk to stopReward to target

Levels are derived from the pattern's structure (resistance, support and ATR) — a mechanical plan, not financial advice. Size positions to your own risk tolerance.

TG THERAPEUTICS, INC.PHARMACEUTICAL PREPARATIONSwww.tgtherapeutics.com ↗
Price57.52
Change+2.71%
Gap-0.26%
Rel volume0.85×
Avg volume1.86M
Avg $ vol104.21M
SMA 2055.72
SMA 5053.56
SMA 20040.58
Price vs 50+7.40%
Price vs 200+41.74%
MA stackbullish
50/200 cross—
Supertrendup · 50.54
RSI (14)59
MACD hist0.11
MACD crossbull · 4d
Stoch %K / %D78 / 73
ADX (14)27
+DI / −DI23 / 14
RSI divergenceBearish
MACD divergenceBearish
ATR %4.23%
ADR %4.16%
52w high59.06
52w low26.94
From 52w high-2.61%
Above 52w low+113.51%
New 52w highNo
SqueezeOn · 7d
Bollinger width9.57%
%B0.84
Donchian pos79.44%
Donchian high58.92
Donchian low52.11
AVWAP (52w high)53.59
vs AVWAP high+7.33%
AVWAP (52w low)45.95
vs AVWAP low+25.17%
OBV trendUp
Chaikin MF (20)0.14
Today vs 20d0.85×
Avg vol (14d)1.87M
Avg vol (20d)1.86M
Avg $ vol (20d)104.21M
Market cap8.8B
RS Rating91 / 99
RS 3m (vs SPY)+2.76%
RS 6m (vs SPY)+63.95%
RS line new highNo
Trend template8/8
Technical rank93.1
1 week+1.86%
1 month+3.79%
3 months+7.25%
6 months+80.77%
1 year+61.71%
YTD+96.45%
P/E19.69
P/B14.57
P/S14.29
P/FCF-352.38
EPS2.77
Div yield—
ROE74.03%
ROA27.27%
Debt/Eq1.23
Current4.27
EV/EBITDA73.49
Gross margin—
Net margin72.56%
Rev growth87.32%
EPS growth1812.41%
Price target69.17
Target upside20.25%
Analyst ratingBuy
Institutional83.61%
Ent. value9.07B
Revenue240.34M
Net income7.78M
Gross profit—
Free cash flow-24.99M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out153.08M
Employees399
ListedThu, Dec 14, 1995
Free float147.28M
Float %96.2%
Short interest30.13M
Days to cover15.9d
Short volume65.8%
Squeeze score82 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.05 vs $0.41
Last surprise-87.8% miss
Setup gradeB
Conviction71 / 100
Pattern quality71%
Tech rank93.1 / 100
Group rank59 / 100
Status laneSetting up
Setup directionLong
Pattern familyBase
Resistance58.92
Support52.11
Days since event—
Candle confirmInside bar

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in TGTX

All disclosures →
No recent disclosed trades by Congress in TGTX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in TGTX

InsiderSideShares
Charney Laurence N
Director · Common Stock · 2026-08-07
Gift500
Charney Laurence N
Director · Common Stock · 2026-08-07
Gift450
Charney Laurence N
Director · Common Stock · 2026-08-06
Gift5.1K

SEC filings

EDGAR filings in TGTX · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.